東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Particle formation by rapid expansio...

Vemavarapu, Chandra S.

FindBook

Google Book

Amazon

博客來

Particle formation by rapid expansion of supercritical solutions.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Particle formation by rapid expansion of supercritical solutions./
作者:	Vemavarapu, Chandra S.
面頁冊數:	360 p.
附註:	Major Professor: Thomas E. Needham.
Contained By:	Dissertation Abstracts International63-05B.
標題:	Chemistry, Pharmaceutical. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3053125
ISBN:	0493679510

Particle formation by rapid expansion of supercritical solutions.
Vemavarapu, Chandra S.

Particle formation by rapid expansion of supercritical solutions. - 360 p.

Major Professor: Thomas E. Needham.

Thesis (Ph.D.)--University of Rhode Island, 2002.

This body of work is intended to serve as a proof of concept for the application of supramolecular chemistry in drug development. More specifically, this work is designed to evaluate crystal doping by recrystallization from supercritical media. The rapid nucleation and growth implicit to supercritical fluid based crystallizations were tested in doping drug crystals with structurally related impurities. The ultimate motive was to tailor the physicochemical properties of active pharmaceutical ingredients (API) through crystal doping. This, in turn provides the ability to tie functionality to API's at early stages of drug discovery and synthesis. The rapid expansion of supercritical solution (RESS) process was evaluated for these purposes. Pure and co-solvent modified supercritical fluid CO<sub>2</sub> was used as the recrystallizing solvent. The supercritical region investigated for these studies included pressures from 1071–9000psi and temperatures ranging from 31–100°C. The pharmaceutical solids studied included α-naphthalene acetic acid, aspirin, benzoic acid, caffeine, chlorpropamide, indomethacin, naproxen, phenytoin, piroxicam, salicylic acid, theobromine, theophylline, tolbutamide and urea. For comparison purposes, model chlorpropamide+urea system was also recrystallized from three liquid organic solvents using evaporative crystallization. The composition, morphology and the energetics of the crystals thus produced are characterized utilizing techniques such as microscopy (polarizing optical, SEM), thermal analysis (DSC, mDSC, TGA and thermomicroscopy) and HPLC. Selective extraction and a reduction in crystallinity were consistently seen in all of the drug-impurity mixtures co-crystallized by RESS process. In addition, a number of interesting phenomena were revealed. These include habit modification, solubility enhancement, particle size reduction, eutectic formation, amorphous conversion, hydrate formation and polymorph conversion. In viewing each of these phenomena from an application standpoint, this work serves as proof of concept for enhancing the physicochemical and mechanical attributes of API's using supercritical fluid crystal doping. Comparative evaluation studies indicated RESS to be superior to organic solvent-based recrystallizations in crystal doping. In summary, RESS offers great promise as a hybrid technique to control both the crystalline and the particle morphologies of APIs in a single stage.

ISBN: 0493679510Subjects--Topical Terms:

550957
Chemistry, Pharmaceutical.

Particle formation by rapid expansion of supercritical solutions.
LDR:03364nam 2200277 a 45 001 932586
005 20110505
008 110505s2002 eng d
020 $a 0493679510
035 $a (UnM)AAI3053125
035 $a AAI3053125
040 $a UnM $c UnM
100 1 $a Vemavarapu, Chandra S. $3 1256326
245 1 0 $a Particle formation by rapid expansion of supercritical solutions.
300 $a 360 p.
500 $a Major Professor: Thomas E. Needham.
500 $a Source: Dissertation Abstracts International, Volume: 63-05, Section: B, page: 2395.
502 $a Thesis (Ph.D.)--University of Rhode Island, 2002.
520 $a This body of work is intended to serve as a proof of concept for the application of supramolecular chemistry in drug development. More specifically, this work is designed to evaluate crystal doping by recrystallization from supercritical media. The rapid nucleation and growth implicit to supercritical fluid based crystallizations were tested in doping drug crystals with structurally related impurities. The ultimate motive was to tailor the physicochemical properties of active pharmaceutical ingredients (API) through crystal doping. This, in turn provides the ability to tie functionality to API's at early stages of drug discovery and synthesis. The rapid expansion of supercritical solution (RESS) process was evaluated for these purposes. Pure and co-solvent modified supercritical fluid CO<sub>2</sub> was used as the recrystallizing solvent. The supercritical region investigated for these studies included pressures from 1071–9000psi and temperatures ranging from 31–100°C. The pharmaceutical solids studied included α-naphthalene acetic acid, aspirin, benzoic acid, caffeine, chlorpropamide, indomethacin, naproxen, phenytoin, piroxicam, salicylic acid, theobromine, theophylline, tolbutamide and urea. For comparison purposes, model chlorpropamide+urea system was also recrystallized from three liquid organic solvents using evaporative crystallization. The composition, morphology and the energetics of the crystals thus produced are characterized utilizing techniques such as microscopy (polarizing optical, SEM), thermal analysis (DSC, mDSC, TGA and thermomicroscopy) and HPLC. Selective extraction and a reduction in crystallinity were consistently seen in all of the drug-impurity mixtures co-crystallized by RESS process. In addition, a number of interesting phenomena were revealed. These include habit modification, solubility enhancement, particle size reduction, eutectic formation, amorphous conversion, hydrate formation and polymorph conversion. In viewing each of these phenomena from an application standpoint, this work serves as proof of concept for enhancing the physicochemical and mechanical attributes of API's using supercritical fluid crystal doping. Comparative evaluation studies indicated RESS to be superior to organic solvent-based recrystallizations in crystal doping. In summary, RESS offers great promise as a hybrid technique to control both the crystalline and the particle morphologies of APIs in a single stage.
590 $a School code: 0186.
650 4 $a Chemistry, Pharmaceutical. $3 550957
650 4 $a Health Sciences, Pharmacy. $3 1017737
690 $a 0491
690 $a 0572
710 2 0 $a University of Rhode Island. $3 1022014
773 0 $t Dissertation Abstracts International $g 63-05B.
790 $a 0186
790 1 0 $a Needham, Thomas E., $e advisor
791 $a Ph.D.
792 $a 2002
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3053125